Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 2
Feb 28, 2025•3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In part two of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss the preclinical data and epidemiological data that led us to the phase three study on exenatide.
Show reference:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract
For the best experience, listen in Metacast app for iOS or Android